01 5Gowling WLG (Canada) LLP
01 12399196
02 12518932
03 12671744
04 12821102
05 12824092
01 5CERITINIB
01 5CAPSULE
01 12021-02-26
02 12024-03-12
03 12027-11-20
04 12031-12-15
05 12032-02-02
Patent Expiration Date : 2021-02-26
Date Granted : 2010-05-04
Brand Name : ZYKADIA
Patent Number : 2399196
Filing Date : 2001-02-26
Strength per Unit : 150 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-02-26
Date Granted : 2010-05-04
Patent Expiration Date : 2027-11-20
Date Granted : 2012-08-28
Brand Name : ZYKADIA
Patent Number : 2671744
Filing Date : 2007-11-20
Strength per Unit : 150 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-11-20
Date Granted : 2012-08-28
Patent Expiration Date : 2024-03-12
Date Granted : 2012-12-04
Brand Name : ZYKADIA
Patent Number : 2518932
Filing Date : 2004-03-12
Strength per Unit : 150 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-03-12
Date Granted : 2012-12-04
Patent Expiration Date : 2032-02-02
Date Granted : 2020-06-30
Brand Name : ZYKADIA
Patent Number : 2824092
Filing Date : 2012-02-02
Strength per Unit : 150 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-02-02
Date Granted : 2020-06-30
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-12-15
Date Granted : 2019-06-11
Brand Name : ZYKADIA
Patent Number : 2821102
Filing Date : 2011-12-15
Strength per Unit : 150 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-12-15
Date Granted : 2019-06-11
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
